logologo

Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com
  • world
  • hkt
  • hkt
  • nl
  • fifa
  • arab
  • zh
  • us
  • th
  • mice
  • business
  • luxury
  • realestate
  • art
  • guestpost
  • blog
  • member
Financial Markets

Alembic Pharma rises after receiving USFDA nod for cancer drug

Alembic Pharmaceuticals rallied 3.74% to Rs 985.55 after the company announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Ivosidenib Tablets.

By: business-standard.com
  • Jul 04 2024
  • 58
  • 7394 Views
Alembic Pharma rises after receiving USFDA nod for cancer drug
Alembic Pharma rises after receiving USFDA nod for cancer drug

Related

PEL board OKs ad hoc appointments post Rupen Patel's passing
Emcure Pharmaceuticals IPO ends with stellar subscription
Tricom Fruit Products reports standalone net loss of Rs 0.05 crore in the June 2024 quarter
Info Edge Q1 FY25 billings climb 11% YoY
Bansal Wire Industries IPO ends with strong subscription
IndusInd Bank advances climb 16% YoY in Q1 FY25
Adani Wilmar reports 13% volume growth in Q1 FY25
Share India Securities allots 16.92 lakh equity shares on conversion of warrants
Marico's domestic biz sees modest volume growth in Q1
Tata Motors JLR wholesale rises 5% YoY in Q1
Dabur India expects mid to high digit revenue growth in Q1
Integra Essentia announces merger with G G Engineering

Facebook

Pinterest

Linkedin

Tumblr

Instagram

Share this page
Guest Posts by Easy Branches
anchor links ads by Easy Branches

Get Reliable Matka Guessing Forum with our Satta Matka Expert and Get all Matka Chart For Free.

Next
PEL board OKs ad hoc appointments post Rupen Patel's passing
Image